xAnts

xAnts

en-IN

Is Hims & Hers Health Stock a Buy?

2025-01-28AOL
Is Hims & Hers Health Stock a Buy?

For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free cash flow of $79.4 million, representing year-over-year revenue growth of 77% and free cash flow growth of 311.4%. ...Read more

Recommendations